These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6460207)

  • 1. An examination of possible interactions between zimelidine, a serotonin uptake inhibitor, and ethanol ingested conjointly in human subjects.
    Brown ZW; Amit Z; Sutherland A; Rockman G; Selvaggi N; Ogren SO
    Neurosci Lett; 1981 Dec; 27(3):351-5. PubMed ID: 6460207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual evoked potentials as a predictor of reported side effects during a trial of zimelidine vs. placebo in chronic pain patients.
    von Knorring L; Johansson F
    Psychiatry Res; 1979 Dec; 1(3):225-30. PubMed ID: 298350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe headache and disturbed liver function during treatment with zimelidine.
    Clarke IM
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1425. PubMed ID: 6215969
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma levels of zimelidine and norzimelidine in endogenous depression.
    Hansen LB; Thomsen IS; Vestergård P; Larsen NE; Hvidberg EF
    Psychopharmacology (Berl); 1980; 69(2):157-60. PubMed ID: 6450427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.
    Aberg-Wistedt A; Jostell KG; Ross SB; Westerlund D
    Psychopharmacology (Berl); 1981; 74(4):297-305. PubMed ID: 6457309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression.
    Georgotas A; Krakowski M; Gershon S
    Am J Psychiatry; 1982 Aug; 139(8):1057-8. PubMed ID: 6211994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of amitriptyline and zimelidine in combination with ethanol.
    Scott DB; Fagan D; Tiplady B
    Psychopharmacology (Berl); 1982; 76(3):209-11. PubMed ID: 6212962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zimelidine: a placebo-controlled trial in depression.
    Norman TR; Burrows GD; Marriott PF; McIntyre IM; Davies BM; Moore RG
    Psychiatry Res; 1983 Feb; 8(2):95-103. PubMed ID: 6222387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zimelidine - a serotonin uptake blocker in the treatment of phobic anxiety.
    Evans L; Best J; Moore G; Cox J
    Prog Neuropsychopharmacol; 1980; 4(1):75-9. PubMed ID: 6447309
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of phobic anxiety by zimelidine.
    Evans L; Moore G
    Acta Psychiatr Scand Suppl; 1981; 290():342-5. PubMed ID: 6452800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of zimelidine and desipramine in endogenous depression.
    Lingjaerde O; Bratfos O; Bratlid T; Haug JO
    Acta Psychiatr Scand; 1983 Jul; 68(1):22-30. PubMed ID: 6225313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of serotonin uptake inhibition by zimelidine on hypothalamic-pituitary-adrenal activity.
    Holsboer F; Müller OA; Winter K; Doerr HG; Sippell WG
    Psychopharmacology (Berl); 1983; 80(1):85-7. PubMed ID: 6306711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of pethidine-induced antinociception by zimelidine, an inhibitor of 5-hydroxytryptamine reuptake.
    Gebhart GF; Lorens SA
    Br J Pharmacol; 1980 Nov; 70(3):411-4. PubMed ID: 6449224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Jul; 66(1):50-65. PubMed ID: 6214925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of zimelidine in humans--plasma levels and urinary excretion of zimelidine and norzimelidine after intravenous and oral administration of zimelidine.
    Love BL; Moore RG; Thomas J; Chaturvedi S
    Eur J Clin Pharmacol; 1981; 20(2):135-9. PubMed ID: 6455297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of amitriptyline, mianserin and zimelidine in depressed patients.
    Burgess CD; Montgomery SA; Montgomery DB; Wadsworth J
    Prog Neuropsychopharmacol; 1980; 4(4-5):523-6. PubMed ID: 6452647
    [No Abstract]   [Full Text] [Related]  

  • 17. Zimelidine to geriatric patients: a pharmacokinetic and clinical study.
    Dehlin O; Björnsson G; Lundström J
    Acta Psychiatr Scand Suppl; 1981; 290():410-24. PubMed ID: 6452803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetics of zimelidine and desipramine in man following acute and chronic administration.
    Potter WZ; Calil HM; Extein I; Zavadil AP; Goodwin FK
    Psychiatry Res; 1979 Dec; 1(3):273-81. PubMed ID: 298355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of serotonin and noradrenaline uptake in human plasma after withdrawal of zimelidine and clomipramine treatment.
    Ross SB; Aberg-Wistedt A
    Psychopharmacology (Berl); 1983; 79(4):298-303. PubMed ID: 6222388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Side effects of a modified type of zimelidine therapy. A review of current reports].
    Lakartidningen; 1983 May; 80(19):2034-7. PubMed ID: 6224063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.